Study of Lutein, Zeaxanthin, and Fish Oil Supplements to Improve Vision, Brain Function, and Bone Health in Healthy Adults Aged 18 to 45

What this Trial Is About

Researchers are studying the effects of lutein, zeaxanthin, and fish oil LZF supplements on healthy adults aged 18 to 45 who have low macular pigment optical density MPOD. The trial aims to find out if taking LZF for six months can improve MPOD, cognitive performance, and bone density compared to a placebo. The study uses a precision nutrition model to address risks related to aging, including macular degeneration, cognitive decline, and bone loss. Participants will be randomly assigned to take either a daily LZF supplement containing 7 mg lutein, 14 mg zeaxanthin, and 245 mg fish oil or a placebo supplement. This treatment lasts for six months. The study is double-blind and controlled, meaning neither participants nor researchers know who receives the supplement or placebo. During the trial, participants will undergo assessments at the start, three months, and six months. These include measuring MPOD, cognitive performance using Neurotracker software, bone density via DXA scans, fasting blood samples, and serum levels of lutein and zeaxanthin. Researchers will track changes over time to understand the impact of the supplements on vision, thinking skills, and bone health.

Lutein, Zeaxathin, and Fish Oil Supplementation